References
Benichou, B. and Strominger, J. L.: Class II-antigen-negative patient and mutant B-cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis. Proc Natl Acad Sci USA 88: 4285–4288, 1991
DePreval, C., Lisowska-Grospierre, B., Loche, M., Griscelli, C., and Mach, B.: A trans-acting class II regulatory gene unlinked to the MHC controls expression of HLA class II genes. Nature 318: 291–293, 1985
DePreval, C., Hadam, M. R., and Mach, B.: Regulation of genes for HLA class II antigens in cell lines from patients with severe combined immunodeficiency. N Engl J Med 318: 1295–1300, 1988
Gönczy, P., Reith, W., Lisowska-Grospierre, B., Griscelli, C., Hadam, M. R., and Mach, B.: Inherited immunodeficiency with a defect in a major histocompatibility complex class II promoter-binding protein differs in the chromatin structure of the HLA-DRA gene. Mol Cell Biol 9: 296–302, 1989
Hume, C. R. and Lee, J. S.: Congenital immunodeficiencies associated with absence of HLA class II antigens on lymphocytes result from distinct mutations in trans-acting factors. Hum Immunol 26: 288–309, 1989
Kara, C. J. and Glimcher, L. H.: In vivo footprinting of MHC class II genes: Bare promoters in the bare lymphocyte syndrome. Science 252: 709–712, 1991
Lisowska-Grospierre, B., Charron, D., DePreval, C., Durandy, A., Griscelli, C., and Mach, B.: A defect in the regulation of major histocompatibility complex class II gene expression in human HLA-DR negative lymphocytes from patients with combined immunodeficiency syndrome. J Clin Invest 76: 381–385, 1985
Mueller, P. R. and Wold, B.: In vivo footprinting of a muscle specific enhancer by ligation mediated PCR. Science 246: 780–786, 1989
Ono, S. J., Bazil, V., Sugawara, M., and Strominger, J. L.: An isotype-specific trans-acting factor is defective in a mutant B cell line that expresses HLA-DQ, but not-DR or-DP. J Exp Med 173: 629–637, 1991
Yang, Z., Accolla, R. S., Pious, D., Zegers, B. J. M., and Strominger, J. L.: Two distinct genetic loci regulating class II gene expression are defective human mutant and patient cell lines. EMBO J 7: 1965–1972, 1988
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kara, C.J., Glimcher, L.H. Three in vivo promoter phenotypes in MHC class II deficient combined immunodeficiency. Immunogenetics 37, 227–230 (1993). https://doi.org/10.1007/BF00191890
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00191890